For research and educational purposes only. Not medical advice.
KPV Reference
Educational, not medical advice reference for KPV: Recovery, Immune; regulatory status, evidence posture, source review, and schedule notes. Also known as Ly…
Reference summary
Preclinical literature documents anti-inflammatory effects in rodent colitis models and transport via PepT1 in intestinal epithelium. Direct human clinical evidence for standalone KPV protocols is limited.
- Categories
- Recovery, Immune
- Aliases
- Lysine-Proline-Valine, α-MSH (11-13) tripeptide
- Evidence posture
- preclinical — Mostly rodent colitis and dermatitis data. Human clinical evidence for KPV itself is limited.
- Regulatory status
- No FDA-approved KPV drug label. KPV is the C-terminal tripeptide fragment of α-MSH and is studied as an anti-inflammatory compound, primarily in animal models of colitis and dermatitis.
- Content review status
- research reference